Contract W91YTZ17C0632
Phadia Us Inc · Department Of Defense · September 3, 2021
Phadia Us Inc was awarded a federal contract by Department Of Defense (Department Of The Army) on September 3, 2021 for $4.21 million (current value) of work in in-vitro diagnostic substance manufacturing. Performance is in Fort Bragg, NC. It was awarded under full and open competition. It uses firm fixed-price contract pricing. If all options are exercised, the contract could reach $4.21 million.
Contract details
- PIID
- W91YTZ17C0632
- Award type
- Definitive Contract
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 325413 · In-Vitro Diagnostic Substance Manufacturing
- Product / service
- In Vitro Diagnostic Substances, Reagents, Test Kits And Sets
- Place of performance
- Fort Bragg, NC
- First action
- September 3, 2021
Description
MOD EXERCISE OF OPTION 4
Modification timeline
-
September 3, 2021Mod P00013 · Exercise An Option$4.21M
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Diasorin Inc | Department Of Defense | December 31, 2025 | $518.8K |
| Bloodworks | Department Of Defense | December 31, 2025 | $160.2K |
| Sl Meditech Co. | Department Of Defense | December 31, 2025 | $151.6K |
| Alba Bioscience, Inc. | Department Of Defense | December 31, 2025 | $163.2K |
| Werfen USA Llc | Department Of Defense | December 31, 2025 | $18.1K |
| Immucor Inc | Department Of Defense | December 31, 2025 | $154.2K |
Top contractors in NAICS 325413
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Biomerieux Inc | 182 | $25.50M |
| 2 | Cepheid | 114 | $20.70M |
| 3 | Roche Diagnostics Corporation | 125 | $13.00M |
| 4 | Quest Diagnostics Incorporated | 8 | $4.31M |
| 5 | Hologic Sales And Service, Llc | 39 | $3.88M |
| 6 | Beckman Coulter, Inc | 28 | $3.40M |
| 7 | Fisher Scientific Company L.L.C. | 52 | $3.04M |
| 8 | Werfen USA Llc | 91 | $2.75M |
| 9 | Diasorin Inc | 21 | $2.74M |
| 10 | Abbott Laboratories Inc. | 10 | $2.69M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract W91YTZ17C0632?
Contract W91YTZ17C0632 is a federal contract awarded to Phadia Us Inc by Department Of Defense on September 3, 2021 for $4.21 million of work classified under IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING. It has been modified 0 times since the base award.
Who won contract W91YTZ17C0632?
Phadia Us Inc won contract W91YTZ17C0632 from Department Of Defense.
How much is contract W91YTZ17C0632 worth?
Contract W91YTZ17C0632 has obligated $0 to date but carries a potential ceiling of $4.21 million if fully funded and all options are exercised.